WESTLAKE CHEMICAL PARTNERS LP
2801 Post Oak Boulevard, Suite 600
Houston, Texas 77056
Via EDGAR
July 15, 2014
Pamela Long
Assistant Director
United States Securities and Exchange Commission
Division of Corporate Finance
100 F Street,
N.E. Washington, D.C. 20549-3561
| Re: | Westlake Chemical Partners LP |
| Registration Statement on Form S-1 |
| File No.: 333-195551 |
Ladies and Gentlemen:
Pursuant to discussions with the staff of the Division of Corporation Finance (the “Staff”) of the Securities and Exchange Commission (the “Commission”), Westlake Chemical Partners LP (the “Partnership,” “we,” “us” or “our”) hereby confidentially submits our currently expected offering terms of the initial public offering (the “Offering”) of our common units representing limited partner interests (the “Common Units”), including the bona fide price range pursuant to Item 501(b)(3) of Regulation S-K, the number of Common Units to be offered, the estimated net proceeds the Partnership expects to receive from the Offering and the total number of Common Units to be outstanding after the Offering. The Partnership expects that these pricing terms will be included in a future amendment to the Registration Statement on Form S-1, File No. 333-195551, as amended (the “Registration Statement”).
The Offering terms are a bona fide estimate of the range of the minimum and maximum offering price and the maximum number of Common Units to be offered as of July 14, 2014. Should the bona fide estimates of these terms change, the figures presented in future amendments to the Registration Statement may increase or decrease.
The Partnership proposes to price the Offering with a bona fide price range of $19 to $21 per Common Unit, with a midpoint of $20 per Common Unit. In the Offering, the Partnership proposes to sell up to 11,250,000 Common Units. The Partnership also proposes to grant the underwriters a 30-day option to purchase up to an aggregate of 1,687,500 additional Common Units from the Partnership. As discussed with members of the Staff, this range is initially being provided for your consideration by correspondence due to the Partnership’s and the underwriters’ concern regarding providing such information in advance of the launch of the Offering given potential market volatility, as well as our desire to provide all information necessary for the Staff to complete its review on a timely basis.
Additionally, the Partnership is enclosing its proposed marked copy of those pages of the Registration Statement that will be affected by the offering terms set forth herein. These marked changes will be incorporated into a future amendment to the Registration Statement. The Partnership seeks confirmation from the Staff that it may launch its Offering with the price range specified herein and include such price range in a future filing of the Registration Statement.
*****
[Remainder of page intentionally blank]
2
Please direct any questions that you have with respect to the foregoing or if any additional supplemental information is required by the Staff, please contact Ramey Layne of Vinson & Elkins L.L.P. at (713) 758-4629 or David Oelman of Vinson & Elkins L.L.P. at (713) 758-3708.
Very truly yours,
WESTLAKE CHEMICAL PARTNERS LP
By: WESTLAKE CHEMICAL PARTNERS GP LLC, its general partner | ||
| By: | /s/ Albert Chao | |
Name: | Albert Chao | |
Title: | President, Chief Executive Officer and Director | |
Enclosures
| cc: | David Oelman – Vinson & Elkins L.L.P. |
| Ramey Layne – Vinson & Elkins L.L.P. |
| William N. Finnegan IV – Latham & Watkins LLP |
3
